Drug Profile
Holmium-166 DOTMP
Alternative Names: Ho-DOTMP; Skeletal targeted radiotherapy; STRLatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Dow Chemical
- Class Antineoplastics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer metastases; Multiple myeloma
Most Recent Events
- 10 May 2005 Discontinued - Phase-I for Cancer metastases in USA (Injection)
- 10 May 2005 Discontinued - Phase-III for Multiple myeloma in Canada (Injection)
- 10 May 2005 Discontinued - Phase-III for Multiple myeloma in USA (Injection)